论文信息 - A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group - 字舞流文

A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group

L. Seymour | H. Hirte | W. Miller | G. Batist | W. Walsh | G. Goss | D. Stewart | D. Parolin | I. Lorimer | S. Stafford | P. Hanna | J. Friedmann | S. Mathews | L. Douglas | D. A. E. Parolin | David J. Stewart | L. Seymour | Ian A. J. Lorimer | G. Batist | Wilson H. Miller